Citigroup’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $617K | Buy |
|
|||||
|
2022
Q4 | $106K | Buy |
|
|||||
|
2022
Q3 | $14K | Sell |
|
|||||
|
2022
Q2 | $24K | Sell |
|
|||||
|
2022
Q1 | $84K | Sell |
|
|||||
|
2021
Q4 | $104K | Sell |
|
|||||
|
2021
Q3 | $338K | Buy |
|
|||||
|
2021
Q2 | $155K | Buy |
|
|||||
|
2021
Q1 | $104K | Sell |
|
|||||
|
2020
Q4 | $249K | Buy |
|
|||||
|
2020
Q3 | $108K | Sell |
|
|||||
|
2020
Q2 | $8.19M | Buy |
|
|||||
|
2020
Q1 | $120K | Buy |
|
|||||
|
2019
Q4 | $54K | Buy |
|